Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionFarallon Capital Management Llc
ManagerThomas Steyer
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Farallon Capital Management Llc closes position in ASND / Ascendis Pharma A/S

On May 15, 2026 - Farallon Capital Management Llc filed a 13F-HR form disclosing ownership of 0 shares of Ascendis Pharma A/S (US:ASND) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 15, 2026 disclosing 0 shares of Ascendis Pharma A/S. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -100.00 0
2026-05-15 2025-12-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -100.00 0
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,400 0 0.00 299 7.19 0.0014
2026-02-17 2025-09-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,400 0 0.00 278 15.35 0.0011
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,400 0 0.00 278 15.35 0.0011
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,400 0 0.00 242 10.55 0.0010
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,400 0 0.00 218 4.31 0.0012
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,400 1,400 209 0.0010
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -109,000 -100.00 0 -100.00
2024-05-24 2024-03-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 109,000 109,000 16,478 0.0747
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 109,000 109,000 16,478 0.0745
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -375,000 -100.00 0 -100.00
2021-08-13 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 375,000 -625,000 -62.50 49,331 -61.72 0.2194
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,000,000 0 0.00 128,880 -22.72 0.7150
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,000,000 -250,000 -20.00 166,780 -13.54 1.0851
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,250,000 110,000 9.65 192,900 14.41 1.3676
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,140,000 -236,349 -17.17 168,606 8.78 1.3836
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,376,349 97,349 7.61 154,991 -12.89 1.3562
2020-02-13 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,279,000 -271,000 -17.48 177,934 19.18 1.4274
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,550,000 10,000 0.65 149,296 -15.81 1.5297
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,540,000 40,000 2.67 177,331 0.44 1.4687
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,500,000 703 0.05 176,550 87.96 1.4188
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,499,297 42,000 2.88 93,931 -9.04 0.7711
2018-11-14 2018-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,457,297 0 0.00 103,264 6.52 0.6100
2018-08-14 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,457,297 170,497 13.25 96,939 15.19 0.5987
2018-05-15 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,286,800 1,286,800 84,157 0.5828
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.